nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxprenolol—Penbutolol—coronary artery disease	0.38	1	CrCtD
Oxprenolol—ADRB1—coronary artery disease	0.0969	0.543	CbGaD
Oxprenolol—ADRB2—coronary artery disease	0.0815	0.457	CbGaD
Oxprenolol—Penbutolol—Timolol—coronary artery disease	0.0729	0.359	CrCrCtD
Oxprenolol—Guaifenesin—Penbutolol—coronary artery disease	0.062	0.306	CrCrCtD
Oxprenolol—Alprenolol—Penbutolol—coronary artery disease	0.0435	0.215	CrCrCtD
Oxprenolol—ADRB2—Penbutolol—coronary artery disease	0.0375	0.223	CbGbCtD
Oxprenolol—ADRB1—Penbutolol—coronary artery disease	0.0369	0.22	CbGbCtD
Oxprenolol—ADRB2—Timolol—coronary artery disease	0.0264	0.157	CbGbCtD
Oxprenolol—ADRB1—Timolol—coronary artery disease	0.026	0.155	CbGbCtD
Oxprenolol—Propranolol—Penbutolol—coronary artery disease	0.0243	0.12	CrCrCtD
Oxprenolol—CYP2D6—Niacin—coronary artery disease	0.00712	0.0424	CbGbCtD
Oxprenolol—CYP2D6—Timolol—coronary artery disease	0.00662	0.0394	CbGbCtD
Oxprenolol—CYP2D6—Captopril—coronary artery disease	0.00583	0.0347	CbGbCtD
Oxprenolol—CYP2D6—Simvastatin—coronary artery disease	0.00563	0.0335	CbGbCtD
Oxprenolol—CYP2D6—Lovastatin—coronary artery disease	0.00551	0.0328	CbGbCtD
Oxprenolol—CYP2D6—Pravastatin—coronary artery disease	0.00551	0.0328	CbGbCtD
Oxprenolol—CYP2D6—Atorvastatin—coronary artery disease	0.00502	0.0299	CbGbCtD
Oxprenolol—Practolol—ADRB1—coronary artery disease	0.000145	0.075	CrCbGaD
Oxprenolol—Metipranolol—ADRB1—coronary artery disease	0.000131	0.0678	CrCbGaD
Oxprenolol—Metipranolol—ADRB2—coronary artery disease	0.00011	0.057	CrCbGaD
Oxprenolol—Esmolol—ADRB1—coronary artery disease	0.000104	0.0539	CrCbGaD
Oxprenolol—Thrombocytopenia—Enalapril—coronary artery disease	9.83e-05	0.00213	CcSEcCtD
Oxprenolol—Insomnia—Valsartan—coronary artery disease	9.81e-05	0.00213	CcSEcCtD
Oxprenolol—Nausea—Gemfibrozil—coronary artery disease	9.79e-05	0.00212	CcSEcCtD
Oxprenolol—Bradycardia—Lisinopril—coronary artery disease	9.77e-05	0.00212	CcSEcCtD
Oxprenolol—Abdominal pain—Clopidogrel—coronary artery disease	9.77e-05	0.00212	CcSEcCtD
Oxprenolol—Insomnia—Olmesartan—coronary artery disease	9.76e-05	0.00211	CcSEcCtD
Oxprenolol—Arthralgia—Perindopril—coronary artery disease	9.75e-05	0.00211	CcSEcCtD
Oxprenolol—Hyperhidrosis—Trandolapril—coronary artery disease	9.75e-05	0.00211	CcSEcCtD
Oxprenolol—Hyperhidrosis—Enalapril—coronary artery disease	9.71e-05	0.0021	CcSEcCtD
Oxprenolol—Abdominal pain—Lovastatin—coronary artery disease	9.7e-05	0.0021	CcSEcCtD
Oxprenolol—Thrombocytopenia—Telmisartan—coronary artery disease	9.7e-05	0.0021	CcSEcCtD
Oxprenolol—Diarrhoea—Acetylsalicylic acid—coronary artery disease	9.63e-05	0.00209	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Niacin—coronary artery disease	9.61e-05	0.00208	CcSEcCtD
Oxprenolol—Dizziness—Rosuvastatin—coronary artery disease	9.58e-05	0.00208	CcSEcCtD
Oxprenolol—Hyperhidrosis—Telmisartan—coronary artery disease	9.57e-05	0.00207	CcSEcCtD
Oxprenolol—Nausea—Ticagrelor—coronary artery disease	9.56e-05	0.00207	CcSEcCtD
Oxprenolol—Dyspepsia—Valsartan—coronary artery disease	9.55e-05	0.00207	CcSEcCtD
Oxprenolol—Insomnia—Niacin—coronary artery disease	9.54e-05	0.00207	CcSEcCtD
Oxprenolol—Abdominal pain—Ezetimibe—coronary artery disease	9.52e-05	0.00206	CcSEcCtD
Oxprenolol—Dyspepsia—Olmesartan—coronary artery disease	9.5e-05	0.00206	CcSEcCtD
Oxprenolol—Palpitations—Losartan—coronary artery disease	9.5e-05	0.00206	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Pravastatin—coronary artery disease	9.46e-05	0.00205	CcSEcCtD
Oxprenolol—Thrombocytopenia—Captopril—coronary artery disease	9.43e-05	0.00204	CcSEcCtD
Oxprenolol—Hypotension—Trandolapril—coronary artery disease	9.42e-05	0.00204	CcSEcCtD
Oxprenolol—Insomnia—Pravastatin—coronary artery disease	9.39e-05	0.00203	CcSEcCtD
Oxprenolol—Hypotension—Enalapril—coronary artery disease	9.38e-05	0.00203	CcSEcCtD
Oxprenolol—Fatigue—Valsartan—coronary artery disease	9.35e-05	0.00203	CcSEcCtD
Oxprenolol—Abdominal pain—Eplerenone—coronary artery disease	9.32e-05	0.00202	CcSEcCtD
Oxprenolol—Dizziness—Acetylsalicylic acid—coronary artery disease	9.31e-05	0.00202	CcSEcCtD
Oxprenolol—Fatigue—Olmesartan—coronary artery disease	9.3e-05	0.00202	CcSEcCtD
Oxprenolol—Dyspepsia—Niacin—coronary artery disease	9.28e-05	0.00201	CcSEcCtD
Oxprenolol—Hypersensitivity—Fenofibrate—coronary artery disease	9.26e-05	0.00201	CcSEcCtD
Oxprenolol—Hypotension—Telmisartan—coronary artery disease	9.25e-05	0.00201	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Trandolapril—coronary artery disease	9.18e-05	0.00199	CcSEcCtD
Oxprenolol—Betaxolol—ADRB1—coronary artery disease	9.17e-05	0.0474	CrCbGaD
Oxprenolol—Thrombocytopenia—Perindopril—coronary artery disease	9.15e-05	0.00198	CcSEcCtD
Oxprenolol—Arthralgia—Losartan—coronary artery disease	9.15e-05	0.00198	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Enalapril—coronary artery disease	9.15e-05	0.00198	CcSEcCtD
Oxprenolol—Dyspepsia—Pravastatin—coronary artery disease	9.14e-05	0.00198	CcSEcCtD
Oxprenolol—Insomnia—Trandolapril—coronary artery disease	9.12e-05	0.00198	CcSEcCtD
Oxprenolol—Hypersensitivity—Clopidogrel—coronary artery disease	9.1e-05	0.00197	CcSEcCtD
Oxprenolol—Atenolol—ADRB1—coronary artery disease	9.08e-05	0.047	CrCbGaD
Oxprenolol—Penbutolol—ADRB1—coronary artery disease	9.08e-05	0.047	CrCbGaD
Oxprenolol—Insomnia—Enalapril—coronary artery disease	9.08e-05	0.00197	CcSEcCtD
Oxprenolol—Abdominal pain—Simvastatin—coronary artery disease	9.08e-05	0.00197	CcSEcCtD
Oxprenolol—Headache—Rosuvastatin—coronary artery disease	9.07e-05	0.00197	CcSEcCtD
Oxprenolol—Hypersensitivity—Lovastatin—coronary artery disease	9.04e-05	0.00196	CcSEcCtD
Oxprenolol—Hyperhidrosis—Perindopril—coronary artery disease	9.04e-05	0.00196	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Telmisartan—coronary artery disease	9.02e-05	0.00196	CcSEcCtD
Oxprenolol—Asthenia—Fenofibrate—coronary artery disease	9.02e-05	0.00195	CcSEcCtD
Oxprenolol—Hypotension—Captopril—coronary artery disease	9e-05	0.00195	CcSEcCtD
Oxprenolol—Insomnia—Telmisartan—coronary artery disease	8.96e-05	0.00194	CcSEcCtD
Oxprenolol—Fatigue—Pravastatin—coronary artery disease	8.95e-05	0.00194	CcSEcCtD
Oxprenolol—Thrombocytopenia—Furosemide—coronary artery disease	8.9e-05	0.00193	CcSEcCtD
Oxprenolol—Pruritus—Fenofibrate—coronary artery disease	8.89e-05	0.00193	CcSEcCtD
Oxprenolol—Dyspepsia—Trandolapril—coronary artery disease	8.87e-05	0.00192	CcSEcCtD
Oxprenolol—Hypersensitivity—Ezetimibe—coronary artery disease	8.87e-05	0.00192	CcSEcCtD
Oxprenolol—Asthenia—Clopidogrel—coronary artery disease	8.87e-05	0.00192	CcSEcCtD
Oxprenolol—Bisoprolol—ADRB1—coronary artery disease	8.85e-05	0.0458	CrCbGaD
Oxprenolol—Dyspepsia—Enalapril—coronary artery disease	8.84e-05	0.00192	CcSEcCtD
Oxprenolol—Asthenia—Lovastatin—coronary artery disease	8.81e-05	0.00191	CcSEcCtD
Oxprenolol—Hyperhidrosis—Furosemide—coronary artery disease	8.79e-05	0.0019	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Captopril—coronary artery disease	8.77e-05	0.0019	CcSEcCtD
Oxprenolol—Esmolol—ADRB2—coronary artery disease	8.76e-05	0.0453	CrCbGaD
Oxprenolol—Pruritus—Clopidogrel—coronary artery disease	8.74e-05	0.00189	CcSEcCtD
Oxprenolol—Hypotension—Perindopril—coronary artery disease	8.74e-05	0.00189	CcSEcCtD
Oxprenolol—Dyspepsia—Telmisartan—coronary artery disease	8.72e-05	0.00189	CcSEcCtD
Oxprenolol—Insomnia—Captopril—coronary artery disease	8.71e-05	0.00189	CcSEcCtD
Oxprenolol—Fatigue—Trandolapril—coronary artery disease	8.69e-05	0.00188	CcSEcCtD
Oxprenolol—Pruritus—Lovastatin—coronary artery disease	8.69e-05	0.00188	CcSEcCtD
Oxprenolol—Fatigue—Enalapril—coronary artery disease	8.66e-05	0.00188	CcSEcCtD
Oxprenolol—Asthenia—Ezetimibe—coronary artery disease	8.64e-05	0.00187	CcSEcCtD
Oxprenolol—Nausea—Rosuvastatin—coronary artery disease	8.6e-05	0.00186	CcSEcCtD
Oxprenolol—Diarrhoea—Fenofibrate—coronary artery disease	8.6e-05	0.00186	CcSEcCtD
Oxprenolol—Thrombocytopenia—Losartan—coronary artery disease	8.59e-05	0.00186	CcSEcCtD
Oxprenolol—Abdominal pain—Valsartan—coronary artery disease	8.57e-05	0.00186	CcSEcCtD
Oxprenolol—Fatigue—Telmisartan—coronary artery disease	8.54e-05	0.00185	CcSEcCtD
Oxprenolol—Abdominal pain—Olmesartan—coronary artery disease	8.53e-05	0.00185	CcSEcCtD
Oxprenolol—Pruritus—Ezetimibe—coronary artery disease	8.52e-05	0.00185	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Perindopril—coronary artery disease	8.52e-05	0.00185	CcSEcCtD
Oxprenolol—Hypotension—Furosemide—coronary artery disease	8.49e-05	0.00184	CcSEcCtD
Oxprenolol—Hyperhidrosis—Losartan—coronary artery disease	8.48e-05	0.00184	CcSEcCtD
Oxprenolol—Dyspepsia—Captopril—coronary artery disease	8.48e-05	0.00184	CcSEcCtD
Oxprenolol—Hypersensitivity—Simvastatin—coronary artery disease	8.46e-05	0.00183	CcSEcCtD
Oxprenolol—Insomnia—Perindopril—coronary artery disease	8.46e-05	0.00183	CcSEcCtD
Oxprenolol—Diarrhoea—Clopidogrel—coronary artery disease	8.46e-05	0.00183	CcSEcCtD
Oxprenolol—Asthenia—Eplerenone—coronary artery disease	8.46e-05	0.00183	CcSEcCtD
Oxprenolol—Diarrhoea—Lovastatin—coronary artery disease	8.4e-05	0.00182	CcSEcCtD
Oxprenolol—Acebutolol—ADRB1—coronary artery disease	8.38e-05	0.0434	CrCbGaD
Oxprenolol—Nausea—Acetylsalicylic acid—coronary artery disease	8.36e-05	0.00181	CcSEcCtD
Oxprenolol—Pruritus—Eplerenone—coronary artery disease	8.34e-05	0.00181	CcSEcCtD
Oxprenolol—Abdominal pain—Niacin—coronary artery disease	8.33e-05	0.00181	CcSEcCtD
Oxprenolol—Dizziness—Fenofibrate—coronary artery disease	8.31e-05	0.0018	CcSEcCtD
Oxprenolol—Fatigue—Captopril—coronary artery disease	8.3e-05	0.0018	CcSEcCtD
Oxprenolol—Asthenia—Simvastatin—coronary artery disease	8.24e-05	0.00179	CcSEcCtD
Oxprenolol—Diarrhoea—Ezetimibe—coronary artery disease	8.24e-05	0.00179	CcSEcCtD
Oxprenolol—Dyspepsia—Perindopril—coronary artery disease	8.23e-05	0.00178	CcSEcCtD
Oxprenolol—Abdominal pain—Pravastatin—coronary artery disease	8.21e-05	0.00178	CcSEcCtD
Oxprenolol—Hypotension—Losartan—coronary artery disease	8.19e-05	0.00178	CcSEcCtD
Oxprenolol—Dizziness—Clopidogrel—coronary artery disease	8.17e-05	0.00177	CcSEcCtD
Oxprenolol—Palpitations—Ramipril—coronary artery disease	8.14e-05	0.00176	CcSEcCtD
Oxprenolol—Pruritus—Simvastatin—coronary artery disease	8.12e-05	0.00176	CcSEcCtD
Oxprenolol—Dizziness—Lovastatin—coronary artery disease	8.12e-05	0.00176	CcSEcCtD
Oxprenolol—Diarrhoea—Eplerenone—coronary artery disease	8.06e-05	0.00175	CcSEcCtD
Oxprenolol—Fatigue—Perindopril—coronary artery disease	8.06e-05	0.00175	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Losartan—coronary artery disease	7.99e-05	0.00173	CcSEcCtD
Oxprenolol—Hypersensitivity—Valsartan—coronary artery disease	7.99e-05	0.00173	CcSEcCtD
Oxprenolol—Abdominal pain—Trandolapril—coronary artery disease	7.97e-05	0.00173	CcSEcCtD
Oxprenolol—Dizziness—Ezetimibe—coronary artery disease	7.96e-05	0.00173	CcSEcCtD
Oxprenolol—Palpitations—Timolol—coronary artery disease	7.96e-05	0.00172	CcSEcCtD
Oxprenolol—Abdominal pain—Enalapril—coronary artery disease	7.94e-05	0.00172	CcSEcCtD
Oxprenolol—Insomnia—Losartan—coronary artery disease	7.93e-05	0.00172	CcSEcCtD
Oxprenolol—Headache—Fenofibrate—coronary artery disease	7.88e-05	0.00171	CcSEcCtD
Oxprenolol—Diarrhoea—Simvastatin—coronary artery disease	7.86e-05	0.0017	CcSEcCtD
Oxprenolol—Arthralgia—Ramipril—coronary artery disease	7.84e-05	0.0017	CcSEcCtD
Oxprenolol—Fatigue—Furosemide—coronary artery disease	7.84e-05	0.0017	CcSEcCtD
Oxprenolol—Abdominal pain—Telmisartan—coronary artery disease	7.83e-05	0.0017	CcSEcCtD
Oxprenolol—Dizziness—Eplerenone—coronary artery disease	7.79e-05	0.00169	CcSEcCtD
Oxprenolol—Asthenia—Valsartan—coronary artery disease	7.78e-05	0.00169	CcSEcCtD
Oxprenolol—Hypersensitivity—Niacin—coronary artery disease	7.77e-05	0.00168	CcSEcCtD
Oxprenolol—Asthenia—Olmesartan—coronary artery disease	7.74e-05	0.00168	CcSEcCtD
Oxprenolol—Headache—Clopidogrel—coronary artery disease	7.74e-05	0.00168	CcSEcCtD
Oxprenolol—Dyspepsia—Losartan—coronary artery disease	7.72e-05	0.00167	CcSEcCtD
Oxprenolol—Betaxolol—ADRB2—coronary artery disease	7.71e-05	0.0399	CrCbGaD
Oxprenolol—Headache—Lovastatin—coronary artery disease	7.69e-05	0.00167	CcSEcCtD
Oxprenolol—Pruritus—Valsartan—coronary artery disease	7.67e-05	0.00166	CcSEcCtD
Oxprenolol—Arthralgia—Timolol—coronary artery disease	7.67e-05	0.00166	CcSEcCtD
Oxprenolol—Hypersensitivity—Pravastatin—coronary artery disease	7.65e-05	0.00166	CcSEcCtD
Oxprenolol—Penbutolol—ADRB2—coronary artery disease	7.64e-05	0.0395	CrCbGaD
Oxprenolol—Atenolol—ADRB2—coronary artery disease	7.64e-05	0.0395	CrCbGaD
Oxprenolol—Pruritus—Olmesartan—coronary artery disease	7.63e-05	0.00165	CcSEcCtD
Oxprenolol—Abdominal pain—Captopril—coronary artery disease	7.61e-05	0.00165	CcSEcCtD
Oxprenolol—Alprenolol—ADRB1—coronary artery disease	7.61e-05	0.0394	CrCbGaD
Oxprenolol—Dizziness—Simvastatin—coronary artery disease	7.59e-05	0.00165	CcSEcCtD
Oxprenolol—Asthenia—Niacin—coronary artery disease	7.56e-05	0.00164	CcSEcCtD
Oxprenolol—Fatigue—Losartan—coronary artery disease	7.56e-05	0.00164	CcSEcCtD
Oxprenolol—Headache—Ezetimibe—coronary artery disease	7.54e-05	0.00163	CcSEcCtD
Oxprenolol—Nausea—Fenofibrate—coronary artery disease	7.47e-05	0.00162	CcSEcCtD
Oxprenolol—Pruritus—Niacin—coronary artery disease	7.46e-05	0.00162	CcSEcCtD
Oxprenolol—Asthenia—Pravastatin—coronary artery disease	7.45e-05	0.00161	CcSEcCtD
Oxprenolol—Bisoprolol—ADRB2—coronary artery disease	7.44e-05	0.0385	CrCbGaD
Oxprenolol—Hypersensitivity—Trandolapril—coronary artery disease	7.43e-05	0.00161	CcSEcCtD
Oxprenolol—Diarrhoea—Valsartan—coronary artery disease	7.42e-05	0.00161	CcSEcCtD
Oxprenolol—Hypersensitivity—Enalapril—coronary artery disease	7.4e-05	0.0016	CcSEcCtD
Oxprenolol—Abdominal pain—Perindopril—coronary artery disease	7.39e-05	0.0016	CcSEcCtD
Oxprenolol—Palpitations—Lisinopril—coronary artery disease	7.38e-05	0.0016	CcSEcCtD
Oxprenolol—Diarrhoea—Olmesartan—coronary artery disease	7.38e-05	0.0016	CcSEcCtD
Oxprenolol—Headache—Eplerenone—coronary artery disease	7.38e-05	0.0016	CcSEcCtD
Oxprenolol—Thrombocytopenia—Ramipril—coronary artery disease	7.36e-05	0.0016	CcSEcCtD
Oxprenolol—Pruritus—Pravastatin—coronary artery disease	7.34e-05	0.00159	CcSEcCtD
Oxprenolol—Nausea—Clopidogrel—coronary artery disease	7.34e-05	0.00159	CcSEcCtD
Oxprenolol—Hypersensitivity—Telmisartan—coronary artery disease	7.3e-05	0.00158	CcSEcCtD
Oxprenolol—Nausea—Lovastatin—coronary artery disease	7.29e-05	0.00158	CcSEcCtD
Oxprenolol—Hyperhidrosis—Ramipril—coronary artery disease	7.27e-05	0.00158	CcSEcCtD
Oxprenolol—Asthenia—Trandolapril—coronary artery disease	7.23e-05	0.00157	CcSEcCtD
Oxprenolol—Diarrhoea—Niacin—coronary artery disease	7.21e-05	0.00156	CcSEcCtD
Oxprenolol—Asthenia—Enalapril—coronary artery disease	7.2e-05	0.00156	CcSEcCtD
Oxprenolol—Headache—Simvastatin—coronary artery disease	7.19e-05	0.00156	CcSEcCtD
Oxprenolol—Abdominal pain—Furosemide—coronary artery disease	7.19e-05	0.00156	CcSEcCtD
Oxprenolol—Dizziness—Valsartan—coronary artery disease	7.17e-05	0.00155	CcSEcCtD
Oxprenolol—Nausea—Ezetimibe—coronary artery disease	7.15e-05	0.00155	CcSEcCtD
Oxprenolol—Dizziness—Olmesartan—coronary artery disease	7.14e-05	0.00155	CcSEcCtD
Oxprenolol—Pruritus—Trandolapril—coronary artery disease	7.13e-05	0.00155	CcSEcCtD
Oxprenolol—Arthralgia—Lisinopril—coronary artery disease	7.11e-05	0.00154	CcSEcCtD
Oxprenolol—Hyperhidrosis—Timolol—coronary artery disease	7.11e-05	0.00154	CcSEcCtD
Oxprenolol—Asthenia—Telmisartan—coronary artery disease	7.11e-05	0.00154	CcSEcCtD
Oxprenolol—Pruritus—Enalapril—coronary artery disease	7.1e-05	0.00154	CcSEcCtD
Oxprenolol—Diarrhoea—Pravastatin—coronary artery disease	7.1e-05	0.00154	CcSEcCtD
Oxprenolol—Metoprolol—ADRB1—coronary artery disease	7.08e-05	0.0366	CrCbGaD
Oxprenolol—Acebutolol—ADRB2—coronary artery disease	7.05e-05	0.0365	CrCbGaD
Oxprenolol—Hypotension—Ramipril—coronary artery disease	7.03e-05	0.00152	CcSEcCtD
Oxprenolol—Pruritus—Telmisartan—coronary artery disease	7.01e-05	0.00152	CcSEcCtD
Oxprenolol—Nausea—Eplerenone—coronary artery disease	7e-05	0.00152	CcSEcCtD
Oxprenolol—Dizziness—Niacin—coronary artery disease	6.97e-05	0.00151	CcSEcCtD
Oxprenolol—Abdominal pain—Losartan—coronary artery disease	6.93e-05	0.0015	CcSEcCtD
Oxprenolol—Asthenia—Captopril—coronary artery disease	6.91e-05	0.0015	CcSEcCtD
Oxprenolol—Diarrhoea—Trandolapril—coronary artery disease	6.9e-05	0.00149	CcSEcCtD
Oxprenolol—Diarrhoea—Enalapril—coronary artery disease	6.87e-05	0.00149	CcSEcCtD
Oxprenolol—Hypotension—Timolol—coronary artery disease	6.87e-05	0.00149	CcSEcCtD
Oxprenolol—Dizziness—Pravastatin—coronary artery disease	6.86e-05	0.00149	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Ramipril—coronary artery disease	6.85e-05	0.00148	CcSEcCtD
Oxprenolol—Nausea—Simvastatin—coronary artery disease	6.82e-05	0.00148	CcSEcCtD
Oxprenolol—Pruritus—Captopril—coronary artery disease	6.81e-05	0.00148	CcSEcCtD
Oxprenolol—Insomnia—Ramipril—coronary artery disease	6.8e-05	0.00147	CcSEcCtD
Oxprenolol—Headache—Valsartan—coronary artery disease	6.79e-05	0.00147	CcSEcCtD
Oxprenolol—Diarrhoea—Telmisartan—coronary artery disease	6.78e-05	0.00147	CcSEcCtD
Oxprenolol—Headache—Olmesartan—coronary artery disease	6.76e-05	0.00146	CcSEcCtD
Oxprenolol—Asthenia—Perindopril—coronary artery disease	6.71e-05	0.00145	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Timolol—coronary artery disease	6.7e-05	0.00145	CcSEcCtD
Oxprenolol—Hypersensitivity—Furosemide—coronary artery disease	6.7e-05	0.00145	CcSEcCtD
Oxprenolol—Thrombocytopenia—Lisinopril—coronary artery disease	6.68e-05	0.00145	CcSEcCtD
Oxprenolol—Dizziness—Trandolapril—coronary artery disease	6.67e-05	0.00144	CcSEcCtD
Oxprenolol—Insomnia—Timolol—coronary artery disease	6.65e-05	0.00144	CcSEcCtD
Oxprenolol—Dizziness—Enalapril—coronary artery disease	6.64e-05	0.00144	CcSEcCtD
Oxprenolol—Dyspepsia—Ramipril—coronary artery disease	6.62e-05	0.00143	CcSEcCtD
Oxprenolol—Pruritus—Perindopril—coronary artery disease	6.61e-05	0.00143	CcSEcCtD
Oxprenolol—Headache—Niacin—coronary artery disease	6.6e-05	0.00143	CcSEcCtD
Oxprenolol—Hyperhidrosis—Lisinopril—coronary artery disease	6.59e-05	0.00143	CcSEcCtD
Oxprenolol—Diarrhoea—Captopril—coronary artery disease	6.59e-05	0.00143	CcSEcCtD
Oxprenolol—Dizziness—Telmisartan—coronary artery disease	6.55e-05	0.00142	CcSEcCtD
Oxprenolol—Pindolol—ADRB1—coronary artery disease	6.55e-05	0.0339	CrCbGaD
Oxprenolol—Asthenia—Furosemide—coronary artery disease	6.52e-05	0.00141	CcSEcCtD
Oxprenolol—Headache—Pravastatin—coronary artery disease	6.5e-05	0.00141	CcSEcCtD
Oxprenolol—Fatigue—Ramipril—coronary artery disease	6.48e-05	0.0014	CcSEcCtD
Oxprenolol—Dyspepsia—Timolol—coronary artery disease	6.47e-05	0.0014	CcSEcCtD
Oxprenolol—Hypersensitivity—Losartan—coronary artery disease	6.46e-05	0.0014	CcSEcCtD
Oxprenolol—Nausea—Valsartan—coronary artery disease	6.44e-05	0.0014	CcSEcCtD
Oxprenolol—Pruritus—Furosemide—coronary artery disease	6.43e-05	0.00139	CcSEcCtD
Oxprenolol—Nausea—Olmesartan—coronary artery disease	6.41e-05	0.00139	CcSEcCtD
Oxprenolol—Alprenolol—ADRB2—coronary artery disease	6.4e-05	0.0331	CrCbGaD
Oxprenolol—Diarrhoea—Perindopril—coronary artery disease	6.4e-05	0.00139	CcSEcCtD
Oxprenolol—Hypotension—Lisinopril—coronary artery disease	6.37e-05	0.00138	CcSEcCtD
Oxprenolol—Dizziness—Captopril—coronary artery disease	6.37e-05	0.00138	CcSEcCtD
Oxprenolol—Fatigue—Timolol—coronary artery disease	6.34e-05	0.00137	CcSEcCtD
Oxprenolol—Headache—Trandolapril—coronary artery disease	6.32e-05	0.00137	CcSEcCtD
Oxprenolol—Asthenia—Losartan—coronary artery disease	6.29e-05	0.00136	CcSEcCtD
Oxprenolol—Headache—Enalapril—coronary artery disease	6.29e-05	0.00136	CcSEcCtD
Oxprenolol—Nausea—Niacin—coronary artery disease	6.26e-05	0.00136	CcSEcCtD
Oxprenolol—Diarrhoea—Furosemide—coronary artery disease	6.22e-05	0.00135	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Lisinopril—coronary artery disease	6.21e-05	0.00135	CcSEcCtD
Oxprenolol—Pruritus—Losartan—coronary artery disease	6.2e-05	0.00134	CcSEcCtD
Oxprenolol—Headache—Telmisartan—coronary artery disease	6.2e-05	0.00134	CcSEcCtD
Oxprenolol—Dizziness—Perindopril—coronary artery disease	6.18e-05	0.00134	CcSEcCtD
Oxprenolol—Insomnia—Lisinopril—coronary artery disease	6.17e-05	0.00134	CcSEcCtD
Oxprenolol—Nausea—Pravastatin—coronary artery disease	6.17e-05	0.00134	CcSEcCtD
Oxprenolol—Headache—Captopril—coronary artery disease	6.03e-05	0.00131	CcSEcCtD
Oxprenolol—Dizziness—Furosemide—coronary artery disease	6.01e-05	0.0013	CcSEcCtD
Oxprenolol—Dyspepsia—Lisinopril—coronary artery disease	6e-05	0.0013	CcSEcCtD
Oxprenolol—Diarrhoea—Losartan—coronary artery disease	6e-05	0.0013	CcSEcCtD
Oxprenolol—Nausea—Trandolapril—coronary artery disease	5.99e-05	0.0013	CcSEcCtD
Oxprenolol—Nausea—Enalapril—coronary artery disease	5.96e-05	0.00129	CcSEcCtD
Oxprenolol—Metoprolol—ADRB2—coronary artery disease	5.95e-05	0.0308	CrCbGaD
Oxprenolol—Abdominal pain—Ramipril—coronary artery disease	5.94e-05	0.00129	CcSEcCtD
Oxprenolol—Nausea—Telmisartan—coronary artery disease	5.88e-05	0.00127	CcSEcCtD
Oxprenolol—Fatigue—Lisinopril—coronary artery disease	5.88e-05	0.00127	CcSEcCtD
Oxprenolol—Headache—Perindopril—coronary artery disease	5.86e-05	0.00127	CcSEcCtD
Oxprenolol—Abdominal pain—Timolol—coronary artery disease	5.81e-05	0.00126	CcSEcCtD
Oxprenolol—Dizziness—Losartan—coronary artery disease	5.8e-05	0.00126	CcSEcCtD
Oxprenolol—Nausea—Captopril—coronary artery disease	5.72e-05	0.00124	CcSEcCtD
Oxprenolol—Headache—Furosemide—coronary artery disease	5.69e-05	0.00123	CcSEcCtD
Oxprenolol—Nausea—Perindopril—coronary artery disease	5.55e-05	0.0012	CcSEcCtD
Oxprenolol—Hypersensitivity—Ramipril—coronary artery disease	5.54e-05	0.0012	CcSEcCtD
Oxprenolol—Pindolol—ADRB2—coronary artery disease	5.51e-05	0.0285	CrCbGaD
Oxprenolol—Headache—Losartan—coronary artery disease	5.49e-05	0.00119	CcSEcCtD
Oxprenolol—Hypersensitivity—Timolol—coronary artery disease	5.42e-05	0.00117	CcSEcCtD
Oxprenolol—Nausea—Furosemide—coronary artery disease	5.4e-05	0.00117	CcSEcCtD
Oxprenolol—Asthenia—Ramipril—coronary artery disease	5.4e-05	0.00117	CcSEcCtD
Oxprenolol—Abdominal pain—Lisinopril—coronary artery disease	5.39e-05	0.00117	CcSEcCtD
Oxprenolol—Pruritus—Ramipril—coronary artery disease	5.32e-05	0.00115	CcSEcCtD
Oxprenolol—Asthenia—Timolol—coronary artery disease	5.27e-05	0.00114	CcSEcCtD
Oxprenolol—Nausea—Losartan—coronary artery disease	5.21e-05	0.00113	CcSEcCtD
Oxprenolol—Pruritus—Timolol—coronary artery disease	5.2e-05	0.00113	CcSEcCtD
Oxprenolol—Diarrhoea—Ramipril—coronary artery disease	5.15e-05	0.00111	CcSEcCtD
Oxprenolol—Metoprolol—CYP2C19—coronary artery disease	5.12e-05	0.0265	CrCbGaD
Oxprenolol—Diarrhoea—Timolol—coronary artery disease	5.03e-05	0.00109	CcSEcCtD
Oxprenolol—Hypersensitivity—Lisinopril—coronary artery disease	5.02e-05	0.00109	CcSEcCtD
Oxprenolol—Dizziness—Ramipril—coronary artery disease	4.97e-05	0.00108	CcSEcCtD
Oxprenolol—Asthenia—Lisinopril—coronary artery disease	4.89e-05	0.00106	CcSEcCtD
Oxprenolol—Dizziness—Timolol—coronary artery disease	4.86e-05	0.00105	CcSEcCtD
Oxprenolol—Pruritus—Lisinopril—coronary artery disease	4.82e-05	0.00105	CcSEcCtD
Oxprenolol—Headache—Ramipril—coronary artery disease	4.71e-05	0.00102	CcSEcCtD
Oxprenolol—Diarrhoea—Lisinopril—coronary artery disease	4.67e-05	0.00101	CcSEcCtD
Oxprenolol—Headache—Timolol—coronary artery disease	4.61e-05	0.000998	CcSEcCtD
Oxprenolol—Dizziness—Lisinopril—coronary artery disease	4.51e-05	0.000977	CcSEcCtD
Oxprenolol—Nausea—Ramipril—coronary artery disease	4.47e-05	0.000968	CcSEcCtD
Oxprenolol—Nausea—Timolol—coronary artery disease	4.37e-05	0.000946	CcSEcCtD
Oxprenolol—Headache—Lisinopril—coronary artery disease	4.27e-05	0.000926	CcSEcCtD
Oxprenolol—Nausea—Lisinopril—coronary artery disease	4.05e-05	0.000878	CcSEcCtD
Oxprenolol—Propranolol—ADRB1—coronary artery disease	3.57e-05	0.0185	CrCbGaD
Oxprenolol—Propranolol—ADRB2—coronary artery disease	3e-05	0.0155	CrCbGaD
Oxprenolol—Propranolol—CYP2C19—coronary artery disease	2.59e-05	0.0134	CrCbGaD
Oxprenolol—ADRB2—Signaling Pathways—DUSP6—coronary artery disease	4.24e-06	0.000183	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—TXNRD1—coronary artery disease	4.21e-06	0.000182	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CYP11B2—coronary artery disease	4.21e-06	0.000182	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PLAT—coronary artery disease	4.17e-06	0.00018	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—SLC22A3—coronary artery disease	4.15e-06	0.000179	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—BDKRB2—coronary artery disease	4.11e-06	0.000177	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CXCL12—coronary artery disease	4.11e-06	0.000177	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—POMC—coronary artery disease	4.11e-06	0.000177	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—F2—coronary artery disease	4.09e-06	0.000177	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—HADH—coronary artery disease	4.09e-06	0.000176	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ARNTL—coronary artery disease	4.09e-06	0.000176	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—IL6ST—coronary artery disease	4.08e-06	0.000176	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—JUNB—coronary artery disease	4.04e-06	0.000174	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CXCL12—coronary artery disease	4.02e-06	0.000173	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—BDKRB2—coronary artery disease	4.02e-06	0.000173	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PLCB1—coronary artery disease	4.02e-06	0.000173	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—POMC—coronary artery disease	4.02e-06	0.000173	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—F2—coronary artery disease	4.01e-06	0.000173	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—IL6ST—coronary artery disease	3.99e-06	0.000172	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—JUNB—coronary artery disease	3.95e-06	0.00017	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—HTR7—coronary artery disease	3.94e-06	0.00017	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PLCB1—coronary artery disease	3.93e-06	0.00017	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GPX2—coronary artery disease	3.88e-06	0.000167	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—APOA2—coronary artery disease	3.88e-06	0.000167	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PLA2G2A—coronary artery disease	3.88e-06	0.000167	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—GSTP1—coronary artery disease	3.86e-06	0.000166	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—HTR7—coronary artery disease	3.85e-06	0.000166	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—SULT1A1—coronary artery disease	3.83e-06	0.000165	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GPX4—coronary artery disease	3.83e-06	0.000165	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ABCG5—coronary artery disease	3.83e-06	0.000165	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—HK1—coronary artery disease	3.83e-06	0.000165	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PPARGC1A—coronary artery disease	3.82e-06	0.000165	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—HMOX1—coronary artery disease	3.81e-06	0.000164	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—HADHA—coronary artery disease	3.78e-06	0.000163	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CAT—coronary artery disease	3.76e-06	0.000162	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—ITGAV—coronary artery disease	3.75e-06	0.000162	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—KNG1—coronary artery disease	3.74e-06	0.000161	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GSTA1—coronary artery disease	3.74e-06	0.000161	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—POMC—coronary artery disease	3.73e-06	0.000161	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—CREB1—coronary artery disease	3.73e-06	0.000161	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—AGTR1—coronary artery disease	3.72e-06	0.00016	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—LPA—coronary artery disease	3.7e-06	0.000159	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—ITGAV—coronary artery disease	3.67e-06	0.000158	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—KNG1—coronary artery disease	3.66e-06	0.000158	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—CCL2—coronary artery disease	3.65e-06	0.000157	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—POMC—coronary artery disease	3.65e-06	0.000157	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—CREB1—coronary artery disease	3.65e-06	0.000157	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—APOB—coronary artery disease	3.65e-06	0.000157	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—AGTR1—coronary artery disease	3.64e-06	0.000157	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—IL6R—coronary artery disease	3.64e-06	0.000157	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CXCL10—coronary artery disease	3.63e-06	0.000157	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PLG—coronary artery disease	3.62e-06	0.000156	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PLCB3—coronary artery disease	3.58e-06	0.000154	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—CCL2—coronary artery disease	3.57e-06	0.000154	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—IL6R—coronary artery disease	3.56e-06	0.000153	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CXCL10—coronary artery disease	3.56e-06	0.000153	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—GSTM1—coronary artery disease	3.55e-06	0.000153	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PLG—coronary artery disease	3.55e-06	0.000153	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—APOA5—coronary artery disease	3.54e-06	0.000153	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—ADRB2—coronary artery disease	3.53e-06	0.000152	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PRKCE—coronary artery disease	3.48e-06	0.00015	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—LPL—coronary artery disease	3.48e-06	0.00015	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—JAK2—coronary artery disease	3.48e-06	0.00015	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—P4HB—coronary artery disease	3.48e-06	0.00015	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—SOCS1—coronary artery disease	3.48e-06	0.00015	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—S100B—coronary artery disease	3.47e-06	0.000149	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—SOCS3—coronary artery disease	3.43e-06	0.000148	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PLA2G1B—coronary artery disease	3.41e-06	0.000147	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PRKCE—coronary artery disease	3.41e-06	0.000147	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—JAK2—coronary artery disease	3.41e-06	0.000147	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—SOCS1—coronary artery disease	3.4e-06	0.000147	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—GPX1—coronary artery disease	3.4e-06	0.000146	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—KITLG—coronary artery disease	3.39e-06	0.000146	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—TGFBR2—coronary artery disease	3.39e-06	0.000146	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—S100B—coronary artery disease	3.39e-06	0.000146	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—SOCS3—coronary artery disease	3.36e-06	0.000145	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—TGFBR2—coronary artery disease	3.32e-06	0.000143	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—KITLG—coronary artery disease	3.32e-06	0.000143	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—MMP3—coronary artery disease	3.32e-06	0.000143	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—STAT5A—coronary artery disease	3.32e-06	0.000143	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CD36—coronary artery disease	3.31e-06	0.000143	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PPP2CA—coronary artery disease	3.27e-06	0.000141	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—MMP3—coronary artery disease	3.24e-06	0.00014	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—STAT5A—coronary artery disease	3.24e-06	0.00014	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—VCAN—coronary artery disease	3.22e-06	0.000139	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—APOB—coronary artery disease	3.2e-06	0.000138	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ALDOA—coronary artery disease	3.19e-06	0.000138	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—CXCL8—coronary artery disease	3.18e-06	0.000137	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—JAK2—coronary artery disease	3.16e-06	0.000136	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—EDN1—coronary artery disease	3.15e-06	0.000136	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—MTHFR—coronary artery disease	3.14e-06	0.000135	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—APOB—coronary artery disease	3.13e-06	0.000135	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CCL5—coronary artery disease	3.13e-06	0.000135	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—CXCL8—coronary artery disease	3.11e-06	0.000134	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—DCN—coronary artery disease	3.1e-06	0.000134	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—JAK2—coronary artery disease	3.09e-06	0.000133	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—EDN1—coronary artery disease	3.08e-06	0.000133	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—FGF1—coronary artery disease	3.08e-06	0.000133	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CSF2—coronary artery disease	3.08e-06	0.000133	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CCL5—coronary artery disease	3.06e-06	0.000132	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—LPL—coronary artery disease	3.06e-06	0.000132	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—RPS6KB1—coronary artery disease	3.03e-06	0.000131	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—MEF2C—coronary artery disease	3.03e-06	0.000131	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CSF2—coronary artery disease	3.02e-06	0.00013	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—FGF1—coronary artery disease	3.02e-06	0.00013	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ALDH2—coronary artery disease	3.01e-06	0.00013	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—LPL—coronary artery disease	2.99e-06	0.000129	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—AGT—coronary artery disease	2.98e-06	0.000128	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—RPS6KB1—coronary artery disease	2.97e-06	0.000128	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—MEF2C—coronary artery disease	2.97e-06	0.000128	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—ITGB3—coronary artery disease	2.95e-06	0.000127	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CYP2C19—coronary artery disease	2.94e-06	0.000127	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—HBA1—coronary artery disease	2.94e-06	0.000127	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PIK3C2A—coronary artery disease	2.94e-06	0.000127	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—LIPC—coronary artery disease	2.94e-06	0.000127	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—APOC3—coronary artery disease	2.92e-06	0.000126	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—APOE—coronary artery disease	2.92e-06	0.000126	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—LDLR—coronary artery disease	2.9e-06	0.000125	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—ITGB3—coronary artery disease	2.89e-06	0.000125	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—APOA1—coronary artery disease	2.89e-06	0.000124	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—CXCL8—coronary artery disease	2.89e-06	0.000124	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PPP2CA—coronary artery disease	2.87e-06	0.000124	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—SLC9A1—coronary artery disease	2.87e-06	0.000124	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GSTT1—coronary artery disease	2.87e-06	0.000124	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GCLC—coronary artery disease	2.83e-06	0.000122	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CETP—coronary artery disease	2.83e-06	0.000122	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—CXCL8—coronary artery disease	2.82e-06	0.000122	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PRKCD—coronary artery disease	2.82e-06	0.000122	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PPP2CA—coronary artery disease	2.81e-06	0.000121	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—SDC1—coronary artery disease	2.8e-06	0.000121	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—HTR2A—coronary artery disease	2.76e-06	0.000119	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PRKCD—coronary artery disease	2.76e-06	0.000119	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—C3—coronary artery disease	2.75e-06	0.000119	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—HTR2A—coronary artery disease	2.7e-06	0.000116	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—C3—coronary artery disease	2.69e-06	0.000116	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PSMB5—coronary artery disease	2.65e-06	0.000114	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PSMA6—coronary artery disease	2.65e-06	0.000114	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—HIF1A—coronary artery disease	2.63e-06	0.000113	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—AGT—coronary artery disease	2.62e-06	0.000113	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CTGF—coronary artery disease	2.59e-06	0.000111	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—HIF1A—coronary artery disease	2.57e-06	0.000111	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—LEP—coronary artery disease	2.56e-06	0.000111	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—APOE—coronary artery disease	2.56e-06	0.000111	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GOT2—coronary artery disease	2.56e-06	0.00011	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—HMGCR—coronary artery disease	2.56e-06	0.00011	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—AGT—coronary artery disease	2.56e-06	0.00011	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PPARG—coronary artery disease	2.54e-06	0.00011	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—APOA1—coronary artery disease	2.54e-06	0.000109	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—KDR—coronary artery disease	2.51e-06	0.000108	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—LEP—coronary artery disease	2.51e-06	0.000108	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—APOE—coronary artery disease	2.51e-06	0.000108	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—POMC—coronary artery disease	2.51e-06	0.000108	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—MAPK14—coronary artery disease	2.5e-06	0.000108	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—APOA1—coronary artery disease	2.48e-06	0.000107	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—KDR—coronary artery disease	2.46e-06	0.000106	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—ESR1—coronary artery disease	2.45e-06	0.000106	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—MAPK14—coronary artery disease	2.44e-06	0.000105	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—F2—coronary artery disease	2.42e-06	0.000104	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—FN1—coronary artery disease	2.42e-06	0.000104	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—IL6ST—coronary artery disease	2.41e-06	0.000104	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—ESR1—coronary artery disease	2.4e-06	0.000103	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—NFKBIA—coronary artery disease	2.39e-06	0.000103	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—FN1—coronary artery disease	2.37e-06	0.000102	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—F2—coronary artery disease	2.37e-06	0.000102	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PLCB1—coronary artery disease	2.36e-06	0.000102	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—IL6ST—coronary artery disease	2.36e-06	0.000102	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—NFKBIA—coronary artery disease	2.34e-06	0.000101	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—KIT—coronary artery disease	2.31e-06	9.98e-05	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—ALB—coronary artery disease	2.29e-06	9.86e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ABCA1—coronary artery disease	2.28e-06	9.85e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—KIT—coronary artery disease	2.26e-06	9.76e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—GSK3B—coronary artery disease	2.22e-06	9.58e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GGT1—coronary artery disease	2.21e-06	9.54e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GOT1—coronary artery disease	2.21e-06	9.54e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—POMC—coronary artery disease	2.2e-06	9.5e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CREB1—coronary artery disease	2.2e-06	9.5e-05	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—NOS3—coronary artery disease	2.19e-06	9.43e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—GSK3B—coronary artery disease	2.17e-06	9.37e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CCL2—coronary artery disease	2.16e-06	9.29e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—POMC—coronary artery disease	2.16e-06	9.29e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CREB1—coronary artery disease	2.16e-06	9.29e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—IL6R—coronary artery disease	2.15e-06	9.27e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—IGF1—coronary artery disease	2.12e-06	9.14e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—MAPK1—coronary artery disease	2.11e-06	9.09e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CCL2—coronary artery disease	2.11e-06	9.09e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—IL6R—coronary artery disease	2.1e-06	9.06e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—IGF1—coronary artery disease	2.07e-06	8.94e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—MAPK1—coronary artery disease	2.06e-06	8.9e-05	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—PIK3CA—coronary artery disease	2.02e-06	8.69e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—SERPINE1—coronary artery disease	2.01e-06	8.68e-05	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PTGS2—coronary artery disease	2e-06	8.62e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GSTP1—coronary artery disease	1.99e-06	8.57e-05	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—PIK3CA—coronary artery disease	1.97e-06	8.5e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	1.97e-06	8.49e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—SERPINE1—coronary artery disease	1.97e-06	8.49e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—HMOX1—coronary artery disease	1.96e-06	8.45e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—FGF2—coronary artery disease	1.95e-06	8.4e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CAT—coronary artery disease	1.93e-06	8.34e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—NOS3—coronary artery disease	1.92e-06	8.28e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—FGF2—coronary artery disease	1.91e-06	8.22e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—NOS3—coronary artery disease	1.88e-06	8.1e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—APOB—coronary artery disease	1.88e-06	8.09e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—JAK2—coronary artery disease	1.87e-06	8.05e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—PIK3CA—coronary artery disease	1.83e-06	7.89e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—JAK2—coronary artery disease	1.83e-06	7.88e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GSTM1—coronary artery disease	1.83e-06	7.87e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—LPL—coronary artery disease	1.79e-06	7.73e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—PIK3CA—coronary artery disease	1.79e-06	7.72e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GPX1—coronary artery disease	1.75e-06	7.54e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CXCL8—coronary artery disease	1.7e-06	7.35e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CD36—coronary artery disease	1.7e-06	7.34e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PPP2CA—coronary artery disease	1.68e-06	7.25e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CXCL8—coronary artery disease	1.67e-06	7.19e-05	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—AKT1—coronary artery disease	1.65e-06	7.1e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CASP3—coronary artery disease	1.63e-06	7.03e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—IL6—coronary artery disease	1.62e-06	6.99e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—MTHFR—coronary artery disease	1.61e-06	6.96e-05	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—AKT1—coronary artery disease	1.61e-06	6.94e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CASP3—coronary artery disease	1.6e-06	6.88e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CCND1—coronary artery disease	1.59e-06	6.85e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—IL6—coronary artery disease	1.59e-06	6.83e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CCND1—coronary artery disease	1.55e-06	6.7e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—MMP9—coronary artery disease	1.54e-06	6.65e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—AGT—coronary artery disease	1.53e-06	6.61e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—MMP9—coronary artery disease	1.51e-06	6.5e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—APOE—coronary artery disease	1.5e-06	6.48e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—AKT1—coronary artery disease	1.5e-06	6.45e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—APOA1—coronary artery disease	1.49e-06	6.4e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—AKT1—coronary artery disease	1.46e-06	6.31e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—VEGFA—coronary artery disease	1.38e-06	5.97e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—VEGFA—coronary artery disease	1.35e-06	5.84e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PPARG—coronary artery disease	1.31e-06	5.64e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—POMC—coronary artery disease	1.29e-06	5.56e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—TGFB1—coronary artery disease	1.27e-06	5.48e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—MAPK1—coronary artery disease	1.25e-06	5.37e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—TGFB1—coronary artery disease	1.24e-06	5.36e-05	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PIK3CA—coronary artery disease	1.23e-06	5.3e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—MAPK1—coronary artery disease	1.22e-06	5.25e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ALB—coronary artery disease	1.18e-06	5.07e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—NOS3—coronary artery disease	1.13e-06	4.85e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PIK3CA—coronary artery disease	1.08e-06	4.66e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PIK3CA—coronary artery disease	1.06e-06	4.56e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PTGS2—coronary artery disease	1.03e-06	4.44e-05	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—AKT1—coronary artery disease	1.01e-06	4.33e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—IL6—coronary artery disease	9.57e-07	4.13e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—IL6—coronary artery disease	9.37e-07	4.04e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—AKT1—coronary artery disease	8.83e-07	3.81e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—AKT1—coronary artery disease	8.64e-07	3.72e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PIK3CA—coronary artery disease	6.33e-07	2.73e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—AKT1—coronary artery disease	5.17e-07	2.23e-05	CbGpPWpGaD
